Immunic, Inc.
IMUX· Nasdaq
IMUXImmunic, Inc.
Filed Mar 20, 2015 · 10-K · 79 days after period end · 0001193125-15-098980
| Metric | Q4 2014 | Q4 2013 |
|---|---|---|
| Net Income | -$13.95M | -$10.24M |
| EPS Diluted | -$0.59 | -$22.28 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Immunic, Inc. · CIK 1280776 · Engraved from SEC EDGAR
ended Dec 31, 2014 · filed Mar 20, 2015 · 79 d after period end
